RE:RE:RE:RE:RE:Comparables I'm not sure about their packaging situation as of today - maybe IR can shed some light.
As for guidance - all I know is what's been floating from the company to a few who have asked about guidance and how they will achieve this. Here is the response-
Our guidance for fiscal 2020 has always been back-half weighted, in the second half of the year, we expect the following to drive revenue:
1. The completion of construction at 7ACRES in January will allow for the facility to reach scaled efficiencies. For example, an increased number of harvests per week. 2. Increased packaging capacity at the 7ACRES facility will allow for the brands full transition to recreational sales in Q3 2020. This will reduce the company’s reliance on the weakening wholesale market and allow for it to meet the demand we have from retailers who are asking for steady supply of 7ACRES product. 3. In the second half of fiscal 2020, we will benefit from two full quarters of Blissco's CBD oil sales. Blissco’s first CBD oil was launched yesterday: https://www.supreme.ca/supreme-cannabis-wellness-focused-brand-blissco-launches-new-cbd-oil-pur-dew 4. In the second half of fiscal 2020, we also expect to benefit from new cannabis convenience (pre-roll) products coming online 5. Lastly, in the 4th quarter of fiscal 2020 we expect to see contributions from our cannabis derivative products (vape pods for our partnership with PAX) The majority of the FY2020 revenue drivers outlined above depend on product sales from proven formats that we see strong demand for in the market. There is proven consumer demand for 7ACRES flower, CBD oils and flower convenience products like pre-rolled joints. Additionally, for an entirely new product format, like vaporizer pods, we have partnered with a well-known brand that is trusted by consumers.